~ FDA sets PDUFA target action date of May 1, 2027 ~ ~ If approved, ifezuntirgene inilparvovec will be the…
$127.3 million in 3Q VYJUVEK global revenue and $1.1 billion since launch VYJUVEK pricing negotiations in Germany and Italy completed…
Company to Host Conference Call at 8:30am ET REHOVOT, Israel and HOBOKEN, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) — Kamada…
REYKJAVIK, Iceland, Nov. 02, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development…
Alvotech (NASDAQ: ALVO, ALVO SDB) kemur fram á fjórum alþjóðlegum fjárfestaráðstefnum í nóvember, í Bretlandi, Noregi og Svíþjóð. Alþjóðleg líftækniráðstefna…
REYKJAVIK, ICELAND (November 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of…
